CIPO trademark

YOBEKRA

RegisteredCIPOWord markClass 5

"YOBEKRA" is a word mark owned by Eli Lilly and Company, filed at the CIPO on July 12, 2024. It is registered and covers class 5 (Pharmaceuticals).

View Eli Lilly and Company portfolioGet this data via the API
Official CIPO record
YOBEKRA
Word mark as filed with the CIPO
Status
Registered
Since March 25, 2026
Filed
July 12, 2024
Registered
March 25, 2026
Expires
March 25, 2036
Application no.
2338154
Registration no.
TMA1397650
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns YOBEKRA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Eli Lilly and Company

LLY · United States

961 trademarks in the portfolioView company

Representative

Borden Ladner Gervais LLP

Borden Ladner Gervais LLP

Goods and services

What the mark covers

The products and services YOBEKRA is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone diseases and disorders and musculoskeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, eczema, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, diabetes, dyslipidemia, endocrine diseases and disorders, namely, growth and thyroid disorders, diabetes and obesity, and hormonal diseases, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases, inflammatory muscle diseases and disorders and pharmaceutical preparations for the treatment of inflammation, namely anti-inflammatory preparations, pharmaceutical preparations for the treatment of kidney diseases and disorders, liver diseases and disorders, lupus, mental health disorders, metabolic diseases and disorders, namely, diabetes, gout, arthritis and anemia, obesity, hyperlipidemia, insulin resistance and metabolic syndrome, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, namely, Alzheimer's, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, amyotrophic lateral sclerosis (ALS), encephalitis, meningitis, muscular dystrophy, myasthenia gravis, dystonia, epilepsy, seizures, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Registered
  2. Registration Pending
  3. Correspondence Created
  4. Note to file; Goods amended as per correspondence dated January 12th 2026.
  5. Advertised; Vol.73 Issue 3715
  6. Approval Notice Sent; APPROVED BY PROGRAM EX200M1
  7. Approved; APPROVED BY PROGRAM EX200M1
  8. Correspondence Created
  9. Examiner's First Report
  10. Search Recorded

4 earlier steps on the official record.

FAQ

About YOBEKRA

Who owns the trademark "YOBEKRA"?

The CIPO trademark "YOBEKRA" (application 2338154) is owned by Eli Lilly and Company.

What is the status of "YOBEKRA"?

Its status at the CIPO is: registered.

When was "YOBEKRA" registered?

It was registered on March 25, 2026 and is due to expire on March 25, 2036.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull YOBEKRA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019deb48-dec8-77bf-9113-4db139a7c979
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019deb48-dec8-77bf-9113-4db139a7c979",
  "object": "trademark",
  "mark_text": "YOBEKRA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "2338154",
  "filing_date": "2024-07-12",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Eli Lilly and Company",
      "entity_id": "ent_019f286c-97ee-774b-84b5-7d5dc09e0b99"
    }
  ]
}